☆ 4.6 Meeting Abstract

BASELINE CHARACTERISTICS AND SAFETY PROFILE OF PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) IN THE FIRST INTERIM ANALYSIS OF THE PEGINTERFERON BETA-1A TREATMENT IN THE PHASE 4 PLEGRIDY OBSERVATIONAL PROGRAM (POP)

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)

Journal

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Volume 89, Issue 6, Pages E29-E29

Publisher

BMJ PUBLISHING GROUP

DOI: 10.1136/jnnp-2018-ANZAN.69

Keywords

Funding

Biogen

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

BASELINE CHARACTERISTICS AND SAFETY PROFILE OF PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) IN THE FIRST INTERIM ANALYSIS OF THE PEGINTERFERON BETA-1A TREATMENT IN THE PHASE 4 PLEGRIDY OBSERVATIONAL PROGRAM (POP)

Journal

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Publisher

BMJ PUBLISHING GROUP

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

BASELINE CHARACTERISTICS AND SAFETY PROFILE OF PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) IN THE FIRST INTERIM ANALYSIS OF THE PEGINTERFERON BETA-1A TREATMENT IN THE PHASE 4 PLEGRIDY OBSERVATIONAL PROGRAM (POP)

Journal

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Publisher

BMJ PUBLISHING GROUP

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper